Position in NVS
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$1,712,792
+$66,453 QoQ
Shares Held
10,929
+1.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#471
of 1,603 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026J.W. COLE ADVISORS, INC. holds $121,333,460 across 13 Drug Manufacturers - General names. NVS ranks #10 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
30,412 | $36,477,068 | |
| 2 | JNJ |
Johnson & Johnson
|
113,666 | $28,867,754 | |
| 3 | ABBV |
AbbVie Inc.
|
73,916 | $18,600,222 | |
| 4 | MRK |
Merck & Co., Inc.
|
100,135 | $12,867,347 | |
| 5 | AMGN |
Amgen Inc
|
16,509 | $5,978,239 | |
| 6 | PFE |
Pfizer Inc
|
235,737 | $5,676,546 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
30,495 | $3,852,738 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
59,835 | $3,447,692 |
All Filings in NVS
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,712,792 | 10,929 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $1,646,339 | 10,778 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $1,458,250 | 10,577 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $1,348,187 | 10,513 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $1,300,131 | 10,744 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,153,706 | 10,349 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $523,527 | 5,380 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $725,776 | 6,310 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $644,402 | 6,053 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $610,753 | 6,314 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $590,674 | 5,850 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $678,795 | 6,664 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $663,685 | 6,577 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $593,952 | 6,456 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $613,176 | 6,759 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $486,768 | 6,404 | Shares | Sole | 2022-10-31 | |
| 2022-06-30 | $508,278 | 6,013 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $533,081 | 6,075 | Shares | Sole | 2022-06-10 | |
| 2021-12-31 | $535,141 | 6,118 | Shares | Sole | 2022-01-25 | |
| 2021-09-30 | $498,121 | 6,091 | Shares | Sole | 2021-10-26 | |
| 2021-06-30 | $512,038 | 5,612 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $299,009 | 3,498 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $340,609 | 3,607 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $629,764 | 7,242 | Shares | Sole | 2020-11-05 | |
| No filing history on record for this holder in this stock. | ||||||